TY - JOUR
T1 - Erratum
T2 - Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction (JAMA Cardiol (2021) DOI: 10.1001/jamacardio.2021.3070)
AU - AbouEzzeddine, O. F.
AU - Davies, D. R.
AU - Scott, C. G.
N1 - Funding Information:
Conflict of Interest Disclosures: Dr Roy has received grants from the French Health Ministry as well as personal fees and nonfinancial support from Bayer Health Care, Boehringer Ingelheim France, Bristol Myers Squibb, Pfizer, Aspen, Daiichi Sankyo, and Sanofi Aventis France. Dr Moumneh has received grants from the French Health Ministry, the Société Française de Médecine d’Urgence, and CanVECTOR Network. Dr Penaloza has received grants from Fondation Saint Luc and Bristol Myers Squibb; grants and personal fees from Bayer; and personal fees and nonfinancial support from Boehringer Ingelheim, Daiichi Sankyo, Sanofi, Stago Diagnostica, Bristol Myers Squibb, Aspen, and Roche.
Publisher Copyright:
© 2021 American Medical Association. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Errors in Key Points, Abstract, Results, and Figures: In the article titled "Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction," published online August 25, 2021, in JAMA Cardiology, 1 the numbers for men andwomenwere given incorrectly in the Key Points, Abstract, text, and Figure 1. In addition, values in the Figure 2 graphswere displayed incorrectly. The article has been corrected.
AB - Errors in Key Points, Abstract, Results, and Figures: In the article titled "Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction," published online August 25, 2021, in JAMA Cardiology, 1 the numbers for men andwomenwere given incorrectly in the Key Points, Abstract, text, and Figure 1. In addition, values in the Figure 2 graphswere displayed incorrectly. The article has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85117747530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117747530&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2021.4325
DO - 10.1001/jamacardio.2021.4325
M3 - Comment/debate
C2 - 34613332
AN - SCOPUS:85117747530
SN - 2380-6583
VL - 6
SP - 1469
JO - JAMA Cardiology
JF - JAMA Cardiology
IS - 12
ER -